Helicobacter Infections: Clinical Trials

4 trials for Helicobacter Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Unknown 4
Phase 21Unknown 1

Follow Helicobacter Infections: new trials by email Literature Review of Helicobacter Infections trials Research Report on Helicobacter Infections

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of Rifabutin for Treatment of Helicobacter Pylori
Rifabutin, Amoxicillin, Esomeprazole - Helicobacter Infections, Resistance Bacterial
Phase 3UnknownRabin Medical Center3002021-05-012021-03-10
A Unique Regimen for Treatment of Helicobacter Pylori Infection
Quadruple therapy, Classic treatment - Helicobacter Infections
Phase 3UnknownSherief Abd-Elsalam6002018-04-012018-04-10
Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) Infection
rabeprazole, amoxicillin, clarithromycin, metronidazole - Helicobacter Infections, Gastritis
Phase 2 / Phase 3UnknownHamamatsu University2003-08-012006-03-21
Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori
Lansoprazole, clarithromycin, amoxicillin - Helicobacter Infections, Gastritis
Phase 3UnknownHamamatsu University2962003-04-012006-09-11

Narrower conditions

Duodenal Ulcer (2)  ·  Gastritis (2)  ·  Stomach Ulcer (2)

Broader conditions

Bacterial Infections (4)  ·  Bacterial Infections and Mycoses (4)  ·  Gram-Negative Bacterial Infections (4)  ·  Infections (4)  ·  Digestive System Diseases (2)  ·  Duodenal Diseases (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Peptic Ulcer (2)  ·  Stomach Diseases (2)

Interventions

Amoxicillin (3)  ·  Clarithromycin (3)  ·  Esomeprazole (1)  ·  Lansoprazole (1)  ·  Metronidazole (1)  ·  Rabeprazole (1)  ·  Rifabutin (1)  ·  Tinidazole (1)

Sponsors

Hamamatsu University (2)  ·  Rabin Medical Center (1)  ·  Sherief Abd-Elsalam (1)

Countries

Japan (2)  ·  Egypt (1)

Top investigators

Asem Elfert, Prof (1)  ·  Ayman Yousry, Prof (1)  ·  Doron Boltin, MBBS (1)  ·  Hussein A Elamin, Prof (1)  ·  Mohamed Adel Elbasiony, MD (1)  ·  Mohamed Alboraie, MD (1)  ·  Naohito Shirai, MD., PhD (1)  ·  Sherief Abd-Elsalam, MD (1)  ·  Takahisa Furuta, MD, PhD (1)  ·  Walied El-Hossary, MD (1)

Results publications

PMID 11197288, PMID 16441468, PMID 32365359, PMID 33037845